301 related articles for article (PubMed ID: 22193544)
1. WW domain-containing oxidoreductase promotes neuronal differentiation via negative regulation of glycogen synthase kinase 3β.
Wang HY; Juo LI; Lin YT; Hsiao M; Lin JT; Tsai CH; Tzeng YH; Chuang YC; Chang NS; Yang CN; Lu PJ
Cell Death Differ; 2012 Jun; 19(6):1049-59. PubMed ID: 22193544
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of WW domain-containing oxidoreductase induces Tau phosphorylation in vitro. A potential role in Alzheimer's disease.
Sze CI; Su M; Pugazhenthi S; Jambal P; Hsu LJ; Heath J; Schultz L; Chang NS
J Biol Chem; 2004 Jul; 279(29):30498-506. PubMed ID: 15126504
[TBL] [Abstract][Full Text] [Related]
3. The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation.
Jämsä A; Hasslund K; Cowburn RF; Bäckström A; Vasänge M
Biochem Biophys Res Commun; 2004 Jul; 319(3):993-1000. PubMed ID: 15184080
[TBL] [Abstract][Full Text] [Related]
4. Glycogen synthase kinase 3beta phosphorylates tau at both primed and unprimed sites. Differential impact on microtubule binding.
Cho JH; Johnson GV
J Biol Chem; 2003 Jan; 278(1):187-93. PubMed ID: 12409305
[TBL] [Abstract][Full Text] [Related]
5. Characterizing WW domain interactions of tumor suppressor WWOX reveals its association with multiprotein networks.
Abu-Odeh M; Bar-Mag T; Huang H; Kim T; Salah Z; Abdeen SK; Sudol M; Reichmann D; Sidhu S; Kim PM; Aqeilan RI
J Biol Chem; 2014 Mar; 289(13):8865-80. PubMed ID: 24550385
[TBL] [Abstract][Full Text] [Related]
6. Glycogen synthase kinase-3β activation mediates rotenone-induced cytotoxicity with the involvement of microtubule destabilization.
Hongo H; Kihara T; Kume T; Izumi Y; Niidome T; Sugimoto H; Akaike A
Biochem Biophys Res Commun; 2012 Sep; 426(1):94-9. PubMed ID: 22922102
[TBL] [Abstract][Full Text] [Related]
7. Primed phosphorylation of tau at Thr231 by glycogen synthase kinase 3beta (GSK3beta) plays a critical role in regulating tau's ability to bind and stabilize microtubules.
Cho JH; Johnson GV
J Neurochem; 2004 Jan; 88(2):349-58. PubMed ID: 14690523
[TBL] [Abstract][Full Text] [Related]
8. Glycogen synthase kinase 3β orchestrates microtubule remodeling in compensatory glomerular adaptation to podocyte depletion.
Xu W; Ge Y; Liu Z; Gong R
J Biol Chem; 2015 Jan; 290(3):1348-63. PubMed ID: 25468908
[TBL] [Abstract][Full Text] [Related]
9. GSKIP, an inhibitor of GSK3beta, mediates the N-cadherin/beta-catenin pool in the differentiation of SH-SY5Y cells.
Lin CC; Chou CH; Howng SL; Hsu CY; Hwang CC; Wang C; Hsu CM; Hong YR
J Cell Biochem; 2009 Dec; 108(6):1325-36. PubMed ID: 19830702
[TBL] [Abstract][Full Text] [Related]
10. The binding and phosphorylation of Thr231 is critical for Tau's hyperphosphorylation and functional regulation by glycogen synthase kinase 3beta.
Lin YT; Cheng JT; Liang LC; Ko CY; Lo YK; Lu PJ
J Neurochem; 2007 Oct; 103(2):802-13. PubMed ID: 17680984
[TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase 3beta interacts with and phosphorylates the spindle-associated protein astrin.
Cheng TS; Hsiao YL; Lin CC; Yu CT; Hsu CM; Chang MS; Lee CI; Huang CY; Howng SL; Hong YR
J Biol Chem; 2008 Jan; 283(4):2454-64. PubMed ID: 18055457
[TBL] [Abstract][Full Text] [Related]
12. NUB1 modulation of GSK3β reduces tau aggregation.
Richet E; Pooler AM; Rodriguez T; Novoselov SS; Schmidtke G; Groettrup M; Hanger DP; Cheetham ME; van der Spuy J
Hum Mol Genet; 2012 Dec; 21(24):5254-67. PubMed ID: 22965877
[TBL] [Abstract][Full Text] [Related]
13. Glycogen synthase kinase-3beta is complexed with tau protein in brain microtubules.
Sun W; Qureshi HY; Cafferty PW; Sobue K; Agarwal-Mawal A; Neufield KD; Paudel HK
J Biol Chem; 2002 Apr; 277(14):11933-40. PubMed ID: 11812770
[TBL] [Abstract][Full Text] [Related]
14. The neuron-specific isoform of glycogen synthase kinase-3beta is required for axon growth.
Castaño Z; Gordon-Weeks PR; Kypta RM
J Neurochem; 2010 Apr; 113(1):117-30. PubMed ID: 20067585
[TBL] [Abstract][Full Text] [Related]
15. 14-3-3 binds to and mediates phosphorylation of microtubule-associated tau protein by Ser9-phosphorylated glycogen synthase kinase 3beta in the brain.
Yuan Z; Agarwal-Mawal A; Paudel HK
J Biol Chem; 2004 Jun; 279(25):26105-14. PubMed ID: 15073173
[TBL] [Abstract][Full Text] [Related]
16. Spectroscopic studies of GSK3{beta} phosphorylation of the neuronal tau protein and its interaction with the N-terminal domain of apolipoprotein E.
Leroy A; Landrieu I; Huvent I; Legrand D; Codeville B; Wieruszeski JM; Lippens G
J Biol Chem; 2010 Oct; 285(43):33435-33444. PubMed ID: 20679343
[TBL] [Abstract][Full Text] [Related]
17. Split GFP complementation assay: a novel approach to quantitatively measure aggregation of tau in situ: effects of GSK3beta activation and caspase 3 cleavage.
Chun W; Waldo GS; Johnson GV
J Neurochem; 2007 Dec; 103(6):2529-39. PubMed ID: 17908237
[TBL] [Abstract][Full Text] [Related]
18. 14-3-3zeta facilitates GSK3beta-catalyzed tau phosphorylation in HEK-293 cells by a mechanism that requires phosphorylation of GSK3beta on Ser9.
Li T; Paudel HK
Neurosci Lett; 2007 Mar; 414(3):203-8. PubMed ID: 17317006
[TBL] [Abstract][Full Text] [Related]
19. Axin negatively affects tau phosphorylation by glycogen synthase kinase 3beta.
Stoothoff WH; Bailey CD; Mi K; Lin SC; Johnson GV
J Neurochem; 2002 Nov; 83(4):904-13. PubMed ID: 12421363
[TBL] [Abstract][Full Text] [Related]
20. Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing.
Wen Y; Planel E; Herman M; Figueroa HY; Wang L; Liu L; Lau LF; Yu WH; Duff KE
J Neurosci; 2008 Mar; 28(10):2624-32. PubMed ID: 18322105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
